Guangzhou, China

Shibo Tang

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Shibo Tang in Ophthalmic Treatments

Introduction

Shibo Tang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of ophthalmology through his innovative research and development. With a total of six patents to his name, Tang's work focuses on methods and compositions for preventing and treating various ophthalmic conditions.

Latest Patents

Among his latest patents, Tang has developed methods for preventing or treating ophthalmic diseases such as diabetic retinopathy, cataracts, retinitis pigmentosa, glaucoma, macular degeneration, choroidal neovascularization, retinal degeneration, and oxygen-induced retinopathy. These methods involve administering an effective amount of an aromatic-cationic peptide to subjects in need of treatment. His research aims to provide new therapeutic options for patients suffering from these debilitating conditions.

Career Highlights

Throughout his career, Shibo Tang has worked with notable companies in the biotherapeutics sector, including Stealth Biotherapeutics Inc. and Stealth Peptides International, Inc. His expertise in the field has allowed him to make substantial advancements in ophthalmic treatments.

Collaborations

Tang has collaborated with esteemed colleagues such as Liping Liu and Xiaoling Liang. These partnerships have further enhanced his research and contributed to the development of innovative solutions in ophthalmology.

Conclusion

Shibo Tang's contributions to ophthalmic research and his innovative patents highlight his commitment to improving patient care. His work continues to pave the way for advancements in the treatment of eye diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…